Events

All Day

9th Liquid Biopsy for Precision Oncology Summit

Liquid biopsy testing has continued to revolutionize diagnostics and personalized medicine; from the integration of AI and automation to elevate liquid biopsy capabilities, to the approval of MRD as an endpoint in Multiple Myeloma.

6th Glioblastoma Drug Development Summit

Boston, MA

Servier’s recent approval of vorasidenib for Grade 2 IDH-mutant glioma has sparked renewed hope in a space that has long struggled with limited treatment options.

email me